Two Sigma Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.44M Sell
268,007
-90,378
-25% -$824K ﹤0.01% 1656
2025
Q1
$2.85M Buy
358,385
+228,635
+176% +$1.82M 0.01% 1460
2024
Q4
$705K Sell
129,750
-32,046
-20% -$174K ﹤0.01% 2308
2024
Q3
$1.17M Sell
161,796
-51,065
-24% -$369K ﹤0.01% 1975
2024
Q2
$2.31M Sell
212,861
-115,986
-35% -$1.26M 0.01% 1390
2024
Q1
$6.16M Buy
328,847
+79,875
+32% +$1.5M 0.01% 818
2023
Q4
$5.4M Buy
+248,972
New +$5.4M 0.01% 894
2023
Q3
Sell
-4,832
Closed -$227K 3099
2023
Q2
$227K Sell
4,832
-42,251
-90% -$1.99M ﹤0.01% 2528
2023
Q1
$1.98M Buy
47,083
+20,190
+75% +$847K 0.01% 1325
2022
Q4
$1.03M Sell
26,893
-109,960
-80% -$4.19M ﹤0.01% 1631
2022
Q3
$5.36M Sell
136,853
-39,172
-22% -$1.53M 0.02% 705
2022
Q2
$5.69M Buy
176,025
+169,706
+2,686% +$5.48M 0.02% 690
2022
Q1
$209K Buy
+6,319
New +$209K ﹤0.01% 2286
2021
Q2
Sell
-150,794
Closed -$11.3M 2827
2021
Q1
$11.3M Buy
150,794
+19,301
+15% +$1.44M 0.03% 543
2020
Q4
$11.4M Buy
131,493
+58,449
+80% +$5.06M 0.03% 478
2020
Q3
$4.46M Sell
73,044
-304,235
-81% -$18.6M 0.02% 647
2020
Q2
$15.7M Sell
377,279
-101,746
-21% -$4.23M 0.08% 242
2020
Q1
$13.8M Buy
479,025
+467,722
+4,138% +$13.4M 0.11% 150
2019
Q4
$816K Buy
+11,303
New +$816K ﹤0.01% 1504
2017
Q4
Sell
-90,596
Closed -$5.64M 2409
2017
Q3
$5.64M Buy
+90,596
New +$5.64M 0.02% 639
2015
Q3
Sell
-38,186
Closed -$2.79M 2020
2015
Q2
$2.79M Buy
+38,186
New +$2.79M 0.01% 921